Navigation Links
Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share
Date:5/23/2013

NEW YORK, May 23, 2013 /PRNewswire/ -- Echo Pharma Acquisition Limited ("Royalty Pharma") announced today that it has committed to waive down the Acceptance Threshold from 90 percent to 50 percent of Maximum Elan Shares Affected plus one Elan Share in accordance with the terms of the Revised Offer Document issued today, subject to the conditions summarized below.

Under the terms of the Increased Offer, Royalty Pharma is offering to acquire Elan (NYSE: ELN) for $12.50 per share in cash. The Increased Offer represents a compelling value of $4.6 billion for Elan's Tysabri Royalty, a 42 percent premium to the $3.25 billion at which Elan sold approximately half of its interest in Tysabri to Biogen. The Increased Offer also represents a premium of 45 percent to the Undisturbed Elan Enterprise Value.

In a letter sent to Elan Stockholders today, Royalty Pharma outlined and reiterated the key points of its Increased Offer:

  • The Increased Offer of $12.50 per Elan Share in cash is fully financed and is not conditional on due diligence;
  • The Increased Offer is conditional on Elan Stockholders voting against the Theravance Transaction and all transactions announced by Elan on May 20, 2013 that are put to a shareholder vote; and
  • Royalty Pharma has committed to waive the Acceptance Threshold from 90 percent to 50 percent of Maximum Shares Affected plus one Elan Share in accordance with the Revised Offer Document.

"The Elan directors have failed to maintain an appropriate balance between supporting management's acquisition plan and their fiduciary responsibilities to Elan shareholders in respect of Royalty Pharma's offer," said Pablo Legorreta , Founder and Chief Executive Officer of Royalty Pharma. "We believe that the increased offer provi
'/>"/>

SOURCE Royalty Pharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Royalty Rates Take Center Stage in Biopharma Dealmaking
2. Royalty Pharma Announces Proposal To Acquire Elan
3. PDL BioPharma Provides First Quarter 2013 Royalty Revenue Guidance of $92 Million
4. Royalty Rates for Pharmaceuticals & Biotechnology: Real-Deal Information for Hundreds of Transactions
5. PDL BioPharma Completes Structured Financing and Royalty Transaction with Avinger
6. Selexis SA Sells Rights to Royalty Payments for More Than 15 Biologic Development Programs to Ligand Pharmaceuticals
7. Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash
8. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
9. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
10. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
11. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... Columbia , May 5, 2015  InMed ... clinical stage biopharmaceutical company that specializes in developing ... former GW Pharmaceuticals financier, investor, and Non-Executive Director, ... InMed as Strategic Advisor with primary responsibility for ... role, Mr. Mountford will leverage his previous success ...
(Date:5/4/2015)... VANCOUVER, British Columbia , May 4, ... announced today that it will report its first quarter ... management will host a conference call and live webcast ... of financial results, clinical development programs and a general ... log on to the Investor Relations page of the ...
(Date:5/4/2015)...  Amgen (NASDAQ: AMGN ) will present at the ... on Thursday, May 7, 2015, at the InterContinental in ... vice president of Global Commercial Operations at Amgen, will present ... accessed from the Events Calendar on Amgen,s website, www.amgen.com ... be available on Amgen,s website for 90 days following the ...
Breaking Medicine Technology:InMed Engages Peter Mountford as Strategic Advisor 2InMed Engages Peter Mountford as Strategic Advisor 3InMed Engages Peter Mountford as Strategic Advisor 4Amgen To Present At The Deutsche Bank 40th Annual Healthcare Conference 2
... 10, 2010 Mylan Inc. (Nasdaq: MYL ... conversion rate applicable to its 6.50% Mandatory Convertible Preferred ... common stock of the company effective as of November ... the governing provisions of the company,s Amended and Restated ...
... Pharmaxis, a global specialty pharmaceutical company focused on therapeutic ... (mannitol inhalation powder) Bronchial Challenge Test Kit, at the ... Asthma and Immunology (ACAAI), November 11-16 in Phoenix, AZ. ... Drug Administration (FDA) on October 5, 2010, ARIDOL is ...
Cached Medicine Technology:Pharmaxis Previews New Bronchial Challenge Test at the Annual Meeting of the American College of Allergy, Asthma and Immunology 2Pharmaxis Previews New Bronchial Challenge Test at the Annual Meeting of the American College of Allergy, Asthma and Immunology 3Pharmaxis Previews New Bronchial Challenge Test at the Annual Meeting of the American College of Allergy, Asthma and Immunology 4Pharmaxis Previews New Bronchial Challenge Test at the Annual Meeting of the American College of Allergy, Asthma and Immunology 5
(Date:5/4/2015)... UK (PRWEB) May 04, 2015 During ... witness a 7.7% CAGR. Currently, the European and APAC ... world, while the North American probiotic market lags behind ... local population. , The North American probiotic market ... over 58%), followed by Canada and Mexico. The North ...
(Date:5/4/2015)... May 04, 2015 HHT is a ... generations. While it can have seemingly mild symptoms ... catastrophic events. Hereditary Hemorrhagic Telangiectasia (HHT) is a ... that lack normal capillary connections between an artery and ... frequent, severe nosebleeds, but may also be present in ...
(Date:5/4/2015)... 2015 Milton Hershey School® has named ... of the Year, recognizing his commitment to pediatric cancer ... sets for MHS students. , “Dr. Graves is a ... children are provided a top-notch education, a nurturing environment, ... said Pete Gurt ’85, president of MHS. “He is ...
(Date:5/4/2015)... 2015 Getting patients to work with ... is critical to achieving the “triple aim” of better ... this will require a shift in thinking from stakeholders ... health systems move beyond their traditional boundaries to reach ... the third live meeting of the ACO and ...
(Date:5/4/2015)... NJ (PRWEB) May 04, 2015 The ... organization devoted exclusively to funding innovative lymphoma research and ... education programs, outreach initiatives and patient services – is ... the historic Mayfair Farms in West Orange, NJ on ... nearly $500,000 for innovative research programs through LRF. , ...
Breaking Medicine News(10 mins):Health News:North America Probiotic Market to Increase by 2019, Announces MicroMarketMonitor in Its New Research Report Recently Published at MarketPublishers.com 2Health News:Frequent Nosebleeds Can Be a Sign of a Rare Undiagnosed Disease - Cure HHT 2Health News:Frequent Nosebleeds Can Be a Sign of a Rare Undiagnosed Disease - Cure HHT 3Health News:Milton Hershey School Names 2015 Alumnus of the Year 2Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 2Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 3Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 4Health News:Lymphoma Research Foundation Set to Host Annual Ace Lymphoma Luncheon at Mayfair Farms in West Orange, NJ 2
... President of India wants the Government and people to ... and organ donation. In India., ,Inaugurating the blood ... Vice President asked the government and people to work in ... blood and organs must be encouraged to save precious lives, ...
... Researchers have found that physical inactivity due to lack ... surrounding area make rural people obese.// ,The study ... link between obesity and the environmental factors within rural ... of Public Health research that examines the environmental features ...
... Obesity in Britain is reaching dangerous proportions, and now ... pangs, might turn out to be just what the ... next big thing in health circles. Accomplia, as the ... brain inactive, and might stop the cravings in their ...
... some progress has been taken to improve the oral ... be investigated - Researchers team reported// in an international ... countries including Australia, China, Finland, Ireland, Japan, Kuwait, Scotland, ... International Association for Dental Research that more work were ...
... 26 issue of Archives of Internal Medicine, which is one ... hot flashes// may have more chronic sleep problems than women ... 85% of women in menopause experience hot flashes, heightened sensations ... explained that hot flashes often occur during the night and ...
... the habit, they may gain about 20 pounds, according to ... commonly cited 5 pounds// to 15 pounds. ,The ... activity counseling along with smoking cessation programs, say study authors ... of the University of California, Berkeley. ,The authors ...
Cached Medicine News:Health News:Environmental Factors Leads to Obesity in Rural Communities 2Health News:Unhealthy Oral Habits among Teenagers – Reported Dental Health Authoritie 2Health News:Women With Severe Hot Flashes May Have Increased Chronic Sleep Problem 2Health News:Smokers are Prone to Weight Gain After Quitting 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: